← Back to blog
GLP-1

How to Inject Tirzepatide: Sites, Rotation, Safety

By TelosRX Editorial Team July 29, 2026
Compounded tirzepatide from telos rx

Tirzepatide is a once-weekly subcutaneous injection, which means it goes into the fat layer just under the skin rather than into muscle or a vein. The FDA-approved tirzepatide labels name the abdomen and the thigh for self-injection, add the back of the upper arm when someone else is doing it, and direct you to rotate sites with each dose. Your telos rx care team walks you through administration before your first injection, and the instructions your own provider gives you are the ones that apply to you.

The short answer

Wash your hands. Inspect the medication. Clean the site and let it dry. Inject into the fat layer of your abdomen or thigh, moving the exact spot each week. Put the used needle straight into a sharps container. Everything specific to you, including the schedule and the amount, comes from your provider.

Start your intake →

How to inject tirzepatide: the sequence, step by step

The mechanics are the same every week once you have done it once. What changes is the spot.

This is general patient education, not a set of instructions for you personally. Your provider and the printed directions that ship with your prescription come first, every time.

  1. Wash your hands. Soap and warm water, then dry them properly. This is the step people skip when they are in a hurry.
  2. Set up a clean surface. Lay out what you need on a wiped-down table rather than a bathroom counter.
  3. Look at the medication. The FDA-approved tirzepatide label says to inspect it visually before use and that it should appear clear and colorless to slightly yellow. Do not use it if you see floating particles or a change in color. Message your care team instead.
  4. Pick your site. Somewhere you have not used recently. More on choosing below.
  5. Clean the skin and wait. An alcohol swab over the spot, then let it air dry completely. Injecting through wet alcohol is one of the most common reasons an injection stings.
  6. Inject as you were shown. Angle, speed, and whether to pinch the skin all depend on the device you were sent and what your provider told you.
  7. Dispose of the needle immediately. Straight into a sharps container, never a bin or a bottle.
  8. Write down where you injected. One line in your phone. It is what makes rotation possible seven days later.

Notice what is not on that list: any amount. Dose is a clinical decision your provider makes and adjusts over time, and it is not something to work out from an article. Start your online visit and a licensed provider will review whether this pathway is appropriate for you.

Where to inject tirzepatide, and the rule that is specific to it

Here is a genuine difference between the two most-searched GLP-1 medications, and most articles miss it.

The FDA-approved semaglutide label lists the abdomen, thigh, and upper arm together for the patient. The FDA-approved tirzepatide labels phrase it differently. Both the Zepbound label and the Mounjaro label on the NIH DailyMed database say to inject "subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm," and to "rotate injection sites with each dose."

Read that carefully. The upper arm is on the list, but it is framed as the site a second person handles.

Abdomen

The one most people settle on. You can see what you are doing, reach it easily, and there is enough surface area to keep moving around for weeks without repeating yourself. Stay well clear of the navel.

Thigh

The front and outer part of the upper leg. A straightforward second area to alternate into, and often the preference of people who find the abdomen uncomfortable.

Back of the upper arm

On the label, but described as the site another person injects. If nobody is around to help you, this is not the one to improvise with. Ask your care team before you use it.

Compounded tirzepatide is not FDA-approved. The anatomy does not change, though, and licensed providers generally work from the same sites and the same rotation principle.

Key takeaway: For tirzepatide, the abdomen and thigh are the practical self-injection sites. The back of the upper arm is described on the label as the one another person injects. Your provider tells you which applies to you.

Rotating sites without overthinking it

Tirzepatide is weekly, so you need a system you will still remember next Tuesday. Two rules cover almost everything.

  • Change the exact spot every single week. Not just the general area. A new patch of skin, every dose.
  • Keep a written log. A note on your phone or a card taped inside a cupboard door. Date and location, nothing more.

A simple pattern that works: divide your abdomen into four sections and count each thigh as its own zone. That gives you six landing places before you circle back, and by then the first one has had well over a month to recover.

Beyond that, a few things to avoid. Skip skin that is bruised, tender, hard, scarred, red, or broken. Feel the area first, and if something is lumpier or firmer than the skin around it, go elsewhere and mention it at your next check-in. Give the navel a wide berth.

The reason the label insists on rotation is that skin used repeatedly can thicken underneath, which makes absorption less predictable. We covered that research in more depth in our guide to where to inject semaglutide, and the principle carries across.

Talk to a licensed provider →

Normal injection-site reaction, or one worth reporting?

Some local response is expected. The Zepbound label lists injection site reactions among the most common adverse reactions, reported in at least 5% of patients in the clinical trials.

Most of it is minor. Here is a plain way to sort routine from report.

Usually routine
  • A small pink or red mark where the needle went in
  • Brief stinging during the injection
  • Mild itching that settles within the hour
  • A pinpoint bruise or one drop of blood
  • Slight tenderness that fades over a day or two
Message your care team
  • Redness or swelling that spreads rather than fades
  • A site that turns hot, hard, or steadily more painful
  • Drainage, pus, or a rash moving outward
  • A lump that is still there when the next dose is due
  • The same reaction at every site, week after week

A severe allergic reaction is a different category altogether. Swelling of the face, lips, tongue, or throat, trouble breathing, or a sudden widespread rash needs emergency care, not a message.

Because telos rx is asynchronous, you can send a note the moment something looks wrong instead of waiting for an appointment slot. For the wider picture, read our guide to tirzepatide side effects.

Preparation hygiene and what happens to the needle

Two details get less attention than they deserve.

Inspect before you use. The label instruction to check that the solution is clear and free of particles exists for a reason. Ten seconds of looking is a real safety step. If a shipment arrives warm, or the liquid looks off, do not use it and message your care team.

Dispose properly. The FDA's guidance on safely using sharps at home, at work and on travel is direct: "Used sharps should be immediately placed in a sharps disposal container." Not a water bottle, not a coffee tin, and never loose in household rubbish. FDA-cleared containers are widely available, and disposal rules vary by state, so check yours.

Never share an injection device with another person, even with a fresh needle. The tirzepatide labels carry an explicit warning about this.

Searching "tirzepatide near me"? You may not need a clinic

Plenty of people search for a nearby provider mainly because they assume they need someone in a room to show them how to inject. That is worth questioning.

The FDA-approved label itself tells prescribers to inform patients which presentation they will receive and to make sure they get appropriate training. It does not require that training to happen in person.

At telos rx, intake takes about five minutes online. A US-licensed provider reviews it asynchronously, usually within hours. Any prescription is subject to medical approval by a licensed provider, and approval is never guaranteed. If you are approved, medication ships with free 48-hour delivery and administration instructions arrive with it. You can message the care team without limits, before your first injection and after it, and get dose adjustments and quarterly labs as part of the program.

None of that depends on your postcode. If you want the full picture of the routes available, read how to get tirzepatide.

You can also see current tirzepatide options and pricing before committing to anything. Compounded tirzepatide is available as low as $139 per month, and compounded semaglutide as low as $99 per month.

Start your online visit →

If you would rather not inject at all

This is where tirzepatide differs from most of the category.

Oral tirzepatide is taken under the tongue, so there is no needle, no sharps container, and no site rotation to track. It is available as low as $129 per month. Microdosed tirzepatide is a different approach again, available as low as $116 per month.

Whether either is suitable for you is a clinical question, not a preference question, and a licensed provider decides. But if needles are the thing standing between you and starting, say so during intake rather than assuming there is no alternative.

For general background on how prescription weight-management medications are used, the NIH NIDDK overview is a reliable starting point.

Frequently Asked Questions

How do you inject tirzepatide?

Tirzepatide is injected subcutaneously, into the fat layer under the skin, once weekly. The general sequence is wash your hands, inspect the medication, clean the site and let it dry, inject as you were shown, and put the needle straight into a sharps container. Follow the specific instructions your licensed provider and your prescription give you.

Where do you inject tirzepatide?

The FDA-approved tirzepatide labels say to inject subcutaneously in the abdomen or thigh, and that another person should inject in the back of the upper arm. The labels also direct you to rotate injection sites with each dose.

Can I inject tirzepatide in my arm myself?

The labels describe the back of the upper arm as the site another person injects, which is a meaningful distinction. Most people self-injecting use the abdomen or thigh. Ask your care team before using the arm on your own.

How often should I change tirzepatide injection sites?

With every dose. Since tirzepatide is once weekly, that means a new spot each week. Rotating within an area matters as much as switching between areas, because repeatedly using the same patch of skin can make absorption less predictable.

Is redness after a tirzepatide injection normal?

A small pink mark, brief stinging, mild itching, or a pinpoint bruise are commonly reported and usually settle quickly. Redness that spreads, a site that becomes hot or hard, drainage, or a lump that persists until the next dose should be reported to your care team.

Does telos rx show me how to inject tirzepatide?

Yes. Administration instructions ship with your prescription, and the care team is available by message to walk you through technique before and after your first injection. telos rx is online-first and asynchronous, so you do not need an appointment to ask.

telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. This article is educational and does not replace the administration instructions given to you by your own licensed provider. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.

Start your private evaluation at telos rx.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX